Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Coleman

Showing results (301-310 of 510) with videos related to

Pageof 51
Sort By:
Current Medical Research and Opinion|June 14, 2014
Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillationWinnie W Nelson, Xue Song, Craig I Coleman, et al.
Journal of Thrombosis and Thrombolysis|June 27, 2020
Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record dataOlivia S Costa, Jan Beyer-Westendorf, Veronica Ashton, et al.
Scientific Reports|September 18, 2024
Toxoplasma FER1 is a versatile and dynamic mediator of differential microneme trafficking and microneme exocytosisDaniel N A Tagoe, Adeline Ribeiro E Silva, Allison A Drozda, et al.
Current Medical Research and Opinion|April 30, 2020
Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record dataOlivia S Costa, Jan Beyer-Westendorf, Veronica Ashton, et al.
The Journal of Innovations in Cardiac Rhythm Management|June 2, 2020
Wearable Cardioverter-defibrillators for the Prevention of Sudden Cardiac Death: A Meta-analysisElaine Nguyen, Erin R Weeda, Christine G Kohn, et al.
Current Medical Research and Opinion|May 12, 2018
CMS hospital readmission reduction program and anticoagulants received following a total hip and knee arthroplasty dischargeFrançois Laliberté, Craig I Coleman, Brahim Bookhart, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 23, 2011
Effect of ascorbic acid on inflammatory markers after cardiothoracic surgeryJennifer A Colby, Wendy T Chen, William L Baker, et al.
Clinical Therapeutics|June 28, 2017
Overall Effectiveness of Rivaroxaban in Patients with Pulmonary EmbolismLi Wang, Onur Baser, Phil Wells, et al.
Pharmacotherapy|September 2, 2004
Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgeryPrabashni Reddy, James S Kalus, Michael F Caron, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 10, 2018
External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancerErin R Weeda, Jonathan T Caranfa, Gary H Lyman, et al.
Pageof 51

Showing results (301-310 of 510) with videos related to

Sort By:
Pageof 51
Current Medical Research and Opinion|June 14, 2014
Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillationWinnie W Nelson, Xue Song, Craig I Coleman, et al.
Journal of Thrombosis and Thrombolysis|June 27, 2020
Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record dataOlivia S Costa, Jan Beyer-Westendorf, Veronica Ashton, et al.
Scientific Reports|September 18, 2024
Toxoplasma FER1 is a versatile and dynamic mediator of differential microneme trafficking and microneme exocytosisDaniel N A Tagoe, Adeline Ribeiro E Silva, Allison A Drozda, et al.
Current Medical Research and Opinion|April 30, 2020
Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record dataOlivia S Costa, Jan Beyer-Westendorf, Veronica Ashton, et al.
The Journal of Innovations in Cardiac Rhythm Management|June 2, 2020
Wearable Cardioverter-defibrillators for the Prevention of Sudden Cardiac Death: A Meta-analysisElaine Nguyen, Erin R Weeda, Christine G Kohn, et al.
Current Medical Research and Opinion|May 12, 2018
CMS hospital readmission reduction program and anticoagulants received following a total hip and knee arthroplasty dischargeFrançois Laliberté, Craig I Coleman, Brahim Bookhart, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 23, 2011
Effect of ascorbic acid on inflammatory markers after cardiothoracic surgeryJennifer A Colby, Wendy T Chen, William L Baker, et al.
Clinical Therapeutics|June 28, 2017
Overall Effectiveness of Rivaroxaban in Patients with Pulmonary EmbolismLi Wang, Onur Baser, Phil Wells, et al.
Pharmacotherapy|September 2, 2004
Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgeryPrabashni Reddy, James S Kalus, Michael F Caron, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 10, 2018
External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancerErin R Weeda, Jonathan T Caranfa, Gary H Lyman, et al.
Pageof 51